Goldman Sachs Group Inc. cut its stake in shares of Concentrix Co. (NASDAQ:CNXC – Free Report) by 27.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 168,808 shares of the company’s stock after selling 63,874 shares during the period. Goldman Sachs Group Inc. owned about 0.25% of Concentrix worth $16,579,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in CNXC. Groupe Bruxelles Lambert acquired a new position in shares of Concentrix during the fourth quarter valued at approximately $861,662,000. Vanguard Group Inc. raised its stake in Concentrix by 1.7% in the 3rd quarter. Vanguard Group Inc. now owns 4,329,347 shares of the company’s stock valued at $346,824,000 after purchasing an additional 71,069 shares during the last quarter. Capital International Investors boosted its stake in Concentrix by 2.6% during the 4th quarter. Capital International Investors now owns 2,518,429 shares of the company’s stock worth $247,335,000 after purchasing an additional 64,001 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Concentrix by 5.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,397,083 shares of the company’s stock worth $137,213,000 after buying an additional 69,081 shares in the last quarter. Finally, AQR Capital Management LLC grew its holdings in shares of Concentrix by 161.3% during the third quarter. AQR Capital Management LLC now owns 794,300 shares of the company’s stock worth $63,488,000 after buying an additional 490,361 shares in the last quarter. 90.34% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Concentrix
In other news, CEO Christopher A. Caldwell purchased 900 shares of the stock in a transaction dated Friday, April 19th. The stock was acquired at an average cost of $54.59 per share, for a total transaction of $49,131.00. Following the completion of the transaction, the chief executive officer now directly owns 239,128 shares in the company, valued at approximately $13,053,997.52. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. In the last three months, insiders have purchased 1,679 shares of company stock worth $98,546. 3.00% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
View Our Latest Report on Concentrix
Concentrix Price Performance
NASDAQ:CNXC opened at $62.77 on Friday. Concentrix Co. has a 52 week low of $53.89 and a 52 week high of $106.10. The stock’s fifty day moving average is $60.23 and its two-hundred day moving average is $73.54. The company has a market capitalization of $4.14 billion, a P/E ratio of 12.94, a P/E/G ratio of 0.69 and a beta of 0.60. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 1.23.
Concentrix (NASDAQ:CNXC – Get Free Report) last issued its quarterly earnings data on Tuesday, March 26th. The company reported $2.33 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.36 by ($0.03). Concentrix had a net margin of 3.53% and a return on equity of 17.70%. The company had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.38 billion. Equities analysts expect that Concentrix Co. will post 11.03 EPS for the current year.
Concentrix Company Profile
Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.
Read More
- Five stocks we like better than Concentrix
- What is the Dow Jones Industrial Average (DJIA)?
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- Best Aerospace Stocks Investing
- Progress Software Stock Back in the Green After Beating Forecasts
- Dividend Capture Strategy: What You Need to Know
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.